Home
Gamida Cell

Gamida Cell Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domaingamida-cell.com

Year Founded1998

Employees51 - 200

Annual Revenue$25M - $50M

Gamida Cell

Gamida Cell (including company regionals)

gamida-cell.com

See more website traffic and engagement information

Gamida Cell Revenue up to August 2026 is 25M - 50M

revenue generated by Gamida Cell top domains

Gamida Cell top domains revenue over 3 years

Revenue for Gamida Cell top domains

gamida-cell.com25M - 50M

See more with Sales Intelligence

Total visits to Gamida Cell's top domains

Understand Gamida Cell market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gamida-cell.com1.3K

See more with Sales Intelligence

Avg. visit duration in Gamida Cell's top domains

Analyze Gamida Cell engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gamida-cell.com00:00:52

See more with Sales Intelligence

Avg. pageviews on Gamida Cell's top domains

See how Gamida Cell keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gamida-cell.com1.81

See more with Sales Intelligence

Gamida Cell top competitors by domain

Top similar sites in August 2026, ranked by their affinity

hbl.co.ilCompany NameHBLEmployees> 10001HQPakistan, KarachiAnnual revenue$500M - $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Gamida Cell

These are the website technologies, by industry, used by Gamida Cell top domains

Social (4)

Google+ Platform

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

eCommerce (2)

WooCommerce

More Technologies

12

See all

News & Signals from Gamida Cell

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGamida Cell Ltd. attends event 2025 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting.The findings were shared by Dr. Ronit Simantov, Chief Medical and Scientific Officer of Gamida Cell, during a presentation at the 2025 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting.

NewsRoyale International partnered with Gamida Cell Ltd. on Sep 16th '25.At Royale International, Royale International specialise in temperature-controlled logistics services, exemplified by its collaboration with Gamida Cell for the transportation of OMISIRGE(R)(omidubicel-onlv), a nicotinamide modified allogeneic hematopoietic progenitor cell therapy.

NewsGamida Cell Ltd. hires Rory Nealon as Chief Commercial Officer.To advance the commercialization of Omisirge(R) (omidubicel-onlv), a NAM-modified cell therapy for allogenic hematopoietic stem cell transplant, Gamida Cell has named industry stalwart Dr. Joe Wiley as Chief Executive Officer, Rory Nealon as Chief Financial Officer, and Sheila Frame as Chief Commercial Officer.